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Summary In resection tissue samples of colorectal carcinomas, the concentration of urokinase-type
plasminogen activator (u-Pa) was found to be significantly higher than in the normal parent mucosal tissue,
while there was less tissue-type plasminogen activator (t-PA). u-PA and t-PA were also determined in
endoscopic biopsies of colonic and gastric carcinomas, and the results were compared with those of the
ultimate resection samples of the same patients, and with the histological evaluation of adjacent biopsies. The
ratio of u-PA/t-PA antigen in the biopsies was found to represent a good discriminator between normal and
malignant tissue. Nearly all (90%) tumour biopsies had a higher PA antigen ratio than that of the normal
tissue biopsies. This discrimination based upon PA antigen measurements in biopsies was similarly efficient in
the subsequent resection samples, and showed a good agreement with the histological evaluation. Thus, PA
antigen measurements in endoscopic biopsies can be used to detect gastrointestinal malignancy.
In many types of malignant tumours, changes in
plasminogen activator (PA) activity have been noticed when
compared with the normal parent tissue (Markus, 1983;
Dan0 et al., 1985). In the colon and rectum, this change
consists of a considerable increase of the urinary-type PA (u-
PA) and frequently a concomitant decrease of the other PA,
tissue-type PA (t-PA) (Gelister et al., 1986; De Bruin et al.,
1987a,b, 1988; Kirchheimer et al., 1987; Nishino et al., 1988;
Sim et al., 1988; Suzumiya et al., 1988). It has been shown
that in the precursor lesion of colonic adenocarcinoma, the
adenomatous polyp, t-PA is at the same level as in
carcinomas, while u-PA levels are intermediate to those in
normal colonic mucosa and carcinoma (Gelister et al., 1986;
De Bruin et al., 1987a; Suzumiya et al., 1988). When PAs
were measured by antigen assays, t-PA levels in adenomas
and carcinomas are half of those in the normal mucosa,
while u-PA antigen in adenomas is about five-fold increased,
and in carcinomas can exceed 10 times the normal level
(Gelister et al., 1986; De Bruin et al., 1988; Sim et al., 1988;
Suzumiya et al., 1988). The great differences found in PA of
malignant and premalignant conditions when compared to
the normal parent tissue, especially in the case of epithelial
cell tumours, could make them of diagnostic, and perhaps
therapeutic, importance (Duffy & O'Grady, 1984). The
pattern of PA present in suspected tissue samples may give
relevant information on the development or presence of
malignancy.
The aim of the present study is to assess the feasibility of
PA measurements in endoscopic biopsies of gastrointestinal
malignancies. This is done by comparison of the results of
PA determinations in biopsies with the corresponding
resection specimens, and by comparison with the results of
histological examination of adjacent biopsies.
Patients, materials and methods
Patients
A group of 14 patients with colorectal carcinoma was
investigated. It consisted of five males and nine females, with
a median age of 69 years (range 46-83) at the moment of
endoscopy. In all cases, subsequent resection of the diseased
part of the colon or rectum was performed. Resection
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followed endoscopy 15 days later (median, range 7-28 days).
In another group of six patients (median age 59 years, range
49-81), adenocarcinomas of the stomach were studied. In
this group, resection took place 20 days after endoscopy
(median, range 7-36 days). Further details of the patients are
given in Table I.
Biopsies
Biopsies were taken during endoscopy from macroscopically
suspected tissue and from the normal mucosa, 5-10cm distal
or proximal from the tumour. From both tumour and
normal tissue, two biopsies were obtained and frozen at
-70°C as soon as possible. The weight of one biopsy
specimen was approximately 5mg.
For routine diagnosis and for reference, adjacent biopsies
were histologically examined by the pathology department.
Resection specimens
After surgery, resection specimens were quickly transferred
to the pathology department, where representative tissue
Table I Patients in the study
Sex Age Localisation Dukes'
(MIF) (years) of the tumour stage
Patients with carcinoma of the colorectum
1 F 80 sigmoid D
2 F 69 sigmoid B2
3 F 60 ascending colon C1
4 F 70 transverse colon B2
5 M 69 rectum C2
6 M 79 rectum Bi
7 M 46 rectum C2
8 M 81 rectum D
9 F 83 caecum BI
10 F 75 sigmoid C1
11 M 68 caecum D
12 F 62 rectum C1
13 F 56 caecum Bi
14 F 55 caecum C1
Patients with carcinoma of the stomach
15 F 60 cardia
16 M 49 cardia
17 F 57 antrum
18 M 81 fundus
19 M 72 antrum
20 M 58 cardia
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samples of tumour and normal mucosa, 5-10 cm from the
macroscopical lesion, were obtained. The samples were
stored at -70°C until extraction.
Tissue extraction
Extracts of resection tissue were prepared from 50-100mg
wet tissue samples as described before (De Bruin et al.,
1988). Essentially, the samples were homogenised at 0°C in
ml 0.1% (v/v) Tween 80, 0.1 M Tris-HCl, pH 7.5, per 60mg
wet tissue. The supernatant was centrifuged twice at 8,000g
for 2.5min. Biopsy tissue extracts were prepared similarly,
except for the wet tissue concentration at homogenisation,
which was 25mgml-'. One extract was prepared from each
pair of equivalent biopsies.
Protein concentrations
Protein concentrations were determined in all extracts
according to the method of Lowry et al. (1951). Samples of
10Ml were diluted 1:50 in aqua dest and assayed in a total
volume of 3.25ml reagents.
ELISA for u-PA
u-PA was determined by a sandwich ELISA using rabbit
anti-u-PA as first antibody and affinity purified goat
anti-u-PA as second antibody. After overnight absorption of
the 1:10 diluted sample followed by the reaction with the
second antibody, u-PA antigen was detected using a rabbit
anti-goat Ig-alkaline phosphatase conjugate and para-nitro-
phenyl-phosphate as substrate. A calibration standard of 0-
Sng u-PAml-1 (National Institute of Biological Standards
and Control, London, batch no. 66/64) was included in this
assay, which had a detection limit of 10pg 100 l-1. This
ELISA was described in detail by Binnema et al. (1986).
ELISA for t-PA
t-PA antigen was measured essentially as described by
Rijken et al. (1984), with minor modifications. Rabbit
anti-t-PA was used as catching antibody, anti-t-PA-horse-
radish peroxidase conjugate (Biopool, Sweden) as second
antibody and 3, 3', 5, 5'tetramethylbenzidine was used as
substrate. Standard t-PA (Biopool, Sweden, 0-4 ngml- 1) was
included for calibration. The detection limit of this assay was
20pg 100pl-1.
Calculations and statistics
Antigen concentrations were expressed as ng antigen per mg
protein. Results are given as mean +s.e. Differences between
groups were statistically tested using Wilcoxon's rank sum
test for unpaired samples (Table II). The paired Wilcoxon
rank sum test was applied to test differences between normal
and tumour tissue of the same patient. Differences were
considered as significant below P=0.05.
Results
The results of the u-PA and t-PA measurements in colonic
tissues are represented in Table II. In the colonic resection
specimens, u-PA and t-PA antigen levels in the tumours were
significantly different from those in the normal tissue
counterparts. Antigen of u-PA was on the average seven
times higher in the tumours, with no overlap (0/14=0%)
with normal mucosa, while t-PA antigen showed a two-fold
decrease (7/14=50% overlap with normal mucosa).
Expressed as a ratio, u-PA/t-PA antigen was 0.3 in the
normal tissues and 3.8 in the tumours. The highest antigen
ratio in the normal tissues (0.6) was still much lower than
the lowest ratio in the tumour group (1.8); thus using this
parameter an absolute discrimination between normal
mucosa and tumour in this group was reached on the basis
of the combined u-PA and t-PA antigen determinations.
In the corresponding colonic biopsies, u-PA antigen
increase in tumours was of the same order (six-fold) as in the
resections, but a t-PA decrease in the tumours could not be
affirmed, because less t-PA was found in the normal biopsies
than in the normal resection samples. When the individual
u-PA/t-PA antigen ratios for the biopsies were calculated,
two of the fourteen tumour ratios fell below the highest
value among the corresponding normal biopsies (1.6),
whereas for u-PA antigen alone this was found to be the
case for four tumours. The average antigen ratios in the
biopsies (0.6 for normal, 4.8 for tumour) were not
significantly different from those in the resections. From
these results, it was concluded that PA-antigen measure-
ments provided a good method to achieve a reliable
discrimination between benign and malignant tissue in
biopsies of the colorectum. With this in mind, measurements
of u-PA and t-PA antigens were performed in another group
of six patients with adenocarcinomas of the stomach.
The results of the antigen assay in this group are given in
Table II. Antigen of u-PA showed the same tendency to
increase strongly in tumour tissue compared to normal, as in
the colorectal tissue sample group. In the tumours, u-PA
antigen was 12-fold increased. On the contrary, t-PA antigen
did not show a significant decrease in tumours compared to
normal gastric mucosa. In bothl biopsies and resections, a
tendency to such a decrease could be seen, but it did not
reach statistical significance. In this group, u-PA and t-PA
antigens in the two biopsy types (normal and tumour) were
not different from the antigens in the corresponding
resection samples. Combined expression of the two antigens
as the ratio u-PA/t-PA antigen resulted in a significant
difference of this parameter between normal and malignant
tissue, in both the biopsy and the resection group (Table II).
No relationship was found between the u-PA/t-PA antigen
ratio and the Dukes' stage or the histological differentiation
of the carcinomas.
The discrimination between normal and tumour for all
tissue samples (colorectum and stomach) using the antigen
Table II Plasminogen activators in gastrointestinal tissue samples
Resection Biopsy
Normal Tumour Normal Tumour
Tissue from the colorectum (n =14)
u-PA (ngmg protein1) 1.7+0.1 11.8+0.9a 2.1+0.4 12.6+2.0a
t-PA (ngmg protein 1) 7.4+0.9 3.5+0.4a 3.8+0.8d 3.1 +0.5
Ratio u-PA/t-PA 0.3+0.1 3.8+0.4a 0.6+0.2e 4.8+0.8a
Tissue from the stomach (n=6)
u-PA (ngmg protein-l) 0.9+0.2 12.1+2.9b 1.1+0.3 12.2+ 1.5c
t-PA (ngmg protein1) 5.6+ 1.0 3.8+ 1.0 6.5+2.1 1.9+0.3
Ratio u-PA/t-PA 0.2+0.1 6.8+3.7b 0.7+0.3 7.2+1.IC
Values are means +s.e.
Significance of difference between tumour and normal: ap<0.001; bp<o.oS; cP<0.01.
Significance of difference between biopsy and resection: dP<O.Ol; eP<0.05.PLASMINOGEN ACTIVATORS IN GASTROINTESTINAL CANCER 39
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Figure 1 Ratios of u-PA/t-PA antigen in endoscopic biopsies
versus subsequent resection samples in patients with gastro-
intestinal malignancies. Colorectal tissue samples are represented
by circles, gastric samples by stars. Broken lines indicate the
99.5% confidence intervals (P<0.005) of the normal tissues
(biopsies ratio 2.25; resections ratio 0.60). Tumour biopsies with
higher antigen ratios are considered to be malignant.
ratio was nearly absolute using the 99.5% confidence
interval (P<0.005) of the normal mucosa (Figure 1): in the
resections only one tumour sample had a ratio within the
normal range, whereas in the biopsies only two tumours had
a ratio within the normal range. All other tumour biopsies
had a higher ratio. Thus, on the basis of u-PA/t-PA antigen
ratio, a good discrimination could be reached in biopsies as
well. For all studied tissue samples (colorectum and
stomach), the concordance of the antigen ratio in the
resection specimen and the corresponding biopsy was high
(r=0.58, P<0.001).
At endoscopy, adjacent biopsies were taken from the
lesion for histological evaluation at the pathology depart-
ment. The data of this evaluation were compared with those
of the PA antigen assays (Table III). Using the PA antigen
Table III Comparison between histological evaluation and u-PA/t-
PA-antigen ratio in endoscopic biopsies
Histology Antigen ratio
Biopsies +above,
positive -below
Biopsies for normal
Patient studied carcinoma range
Tumour biopsies from the colorectum
1 5 1 _a
2 3 3 +
3 5 5 +
4 8 8 +
5 5 5 +
6 7 7 +
7 7 3 +
8 8 1 _a
9 5 5 +
10 8 oa +
11 2 oa +
12 10 10 +
13 6 3 +
14 7 7 +
Tumour biopsies from the stomach
15 4 4 +
16 6 6 +
17 2 2 +
18 5 5 +
19 6 3 +
20 4 3 +
aResult discordant with the diagnosis after subsequent resection.
Discussion
In this study, a comparison was made between plasminogen
activator content of resections of colorectal and stomach
malignancies and preceding biopsies. A second comparison
was made between the eventual malignancy as judged by the
u-PA and t-PA antigen content of these biopsies and the
histology of adjacent biopsies.
In the colon and rectum, a good general agreement was
found between PA antigen concentrations of biopsy and
resection. A minor difference was found in the t-PA antigen
levels, which were lower in the endoscopical biopsies than in
the resection specimens. This phenomenon can be attributed
to the presence of fewer t-PA producing endothelial cells in
the superficial biopsies compared to the resection samples
which were dissected at the muscular layer and contain
relatively more mucosal tissue. In both cases, a strong
increase of u-PA antigen was seen, while t-PA antigen
remained unchanged, or was lower, when samples of adeno-
carcinoma were compared with the normal mucosa which
corresponds with previous reports on resection specimens
(Gelister et al., 1986; De Bruin et al., 1987a,b, 1988;
Kirchheimer et al., 1987; Nishino et al., 1988; Sim et al.,
1988; Suzumiya et al., 1988).
Determination of the u-PA/t-PA antigen ratio in tumour
biopsies from the stomach resulted in a detection of
malignancy without false negatives and completely
paralleling the histological evaluation. However, the
resection tissue sample of one of the gastric carcinomas (case
no. 17) did not show the expected incre'ased u-PA level
(activity as well as antigen) nor did it show a decreased t-PA
level characteristic of carcinomas. According to the
pathologist's report, the exact borders of this particular
tumour were unclear, so that the dimensions could not be
determined. Hence, there is a real possibility that the sample
investigated for u-PA and t-PA did not originate from the
actual carcinoma, which would explain the aberrant result.
In the colon, in two instances, malignancy was not found by
histology, but was evident using the u-PA/t-PA antigen ratio.
Conversely, two other cases were negative in the biopsy
antigen test, while positive for carcinoma by histology in
both the corresponding biopsies and the subsequent
resection. In the first case only one biopsy out of five was
histologically positive, and in the second case all eight
tumour biopsies showed a virtually normal mucosal surface,
while in only one of these a few malignant cells were seen in
a lymph vessel. If in the adjacent biopsies used for u-PA and
t-PA antigen determinations, malignant cells formed only a
minority, it is expected that PA antigens showed levels of
normal mucosa due to a dilution effect.
Taking biopsies by endoscopy is subject to sampling error,
which increases when the suspected lesion is smaller, more
difficult to discern from normal or of heterogeneous
composition. To compensate for this, usually five to ten
tissue samples are taken and all are histologically evaluated
(Dekker & Tytgat, 1977). In the experiments described in
this study, only two biopsies from a lesion were used for PA
antigen measurements. A considerable sampling error could
thus be expected, and the two false negative cases may be
ascribed to this cause.
Immunological assays for a large variety of antigens have400 P.A.F. DE BRUIN et al.
come widely into use, and are easily performed and auto-
mated. We have shown, for the first time, that measurement
of u-PA and t-PA antigens in endoscopic biopsies could
form a quick and simple routine method for the detection of
gastrointestinal malignancy, validated by comparison with
resection specimens and classical histology. Moreover, since
clear PA antigen changes have also been detected in pre-
malignant lesions (Gelister et al., 1986; De Bruin et al., 1988;
Sim et al., 1988; Suzumiya et al., 1988), PA determinations
in endoscopical biopsies may help to facilitate the study on
the relation between PA and the development of gastric or
intestinal cancer in follow-up studies.
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